
In this episode of The BioHub Podcast, Max sits down with Randy Teel, President and CEO of Arvinas.Randy joined Arvinas in 2018 as Vice President of Corporate Development and has since helped guide the company through a period of significant growth, ultimately stepping into the CEO role. Today, Arvinas is one of the pioneers in targeted protein degradation, using its PROTAC platform to develop therapies designed to eliminate disease-causing proteins.In this conversation, we discuss Randy’s journey from strategy and corporate development into the CEO seat, the evolution of Arvinas from an emerging platform company to an industry leader, and the challenges of building and scaling a biotech company.We also explore the future of targeted protein degradation, the company’s unique partnership approach, and what’s next for Arvinas and its pipeline.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode 185 - Ed Ahn - Medipost INC

Episode 183 - Matt Erick - CCO Biocon Biologics

Episode 182 - David Solomon - CEO of Thalia Therapeutics

Episode 181 - Pete Smith - Co-Founder, CEO & President of Remix Therapeutics
Free AI-powered recaps of The BioHub - by Avetix and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.